NCT05388955已完成不适用
A Pre-transplantation Risk Assessment Tool for Graft Survival After Pediatric Kidney Transplantation Based on 1425 Dutch Transplantations
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,425
- 主要终点
- Graft survival
研究概览
简要总结
Registry study in which data of all pediatric kidney recipients in the Netherlands (registered in the Nederlandse Orgaan Transplantatie Registry) are studied to develop a risk calculator for graft loss.
详细描述
The pre-transplantation parameters of all recipients are used to do a multivariable regression analysis.
The B-coefficients of this analysis will be used to develop a risk calculator that predicts graft survival after transplantation per year of transplantation.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 0 Years 至 18 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pediatric kidney recipients
- •transplantation in the Netherlands
- •signed informed consent
排除标准
- •combined transplantation (pancreas-kidney of liver-kidney transplantation)
- •No informed consent
结局指标
主要结局
Graft survival
时间窗: Up to 50 years after transplantation
Functioning graft of death with functioning graft. Survival graph: Percentage recipients with a functioning graft over time
次要结局
未报告次要终点
研究者
相似试验
终止
不适用
TruGraf® Testing in High-Risk Kidney Transplant RecipientsKidney Transplant RejectionNCT04266613Transplant Genomics, Inc.19
已完成
不适用
Development and Validation of a Clinical Risk Prediction Model for Early Acute Kidney Injury Within 48 Hours After Liver TransplantationLiver TransplantationModelAcute Kidney InjuryNCT06750770Beijing Tsinghua Chang Gung Hospital453
已完成
不适用
Use of Predigraft in Kidney Transplant PatientsKidney TransplantNCT04969757Assistance Publique - Hôpitaux de Paris50
已完成
不适用
Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy RegionsCancer of KidneyNCT02121730Centre Hospitalier Universitaire, Amiens2,500
已完成
3 期
Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant RecipientsRenal Allograft RecipientsNCT00470665Wyeth is now a wholly owned subsidiary of Pfizer460
